Page last updated: 2024-08-17

levodopa and way 100135

levodopa has been researched along with way 100135 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, M; Inden, M; Kitamura, Y; Minamino, H; Takata, K; Tooyama, I; Yoshimoto, K	1

Other Studies

1 other study(ies) available for levodopa and way 100135

Article	Year
Effect of selective serotonin reuptake inhibitors via 5-HT1A receptors on L-DOPA-induced rotational behavior in a hemiparkinsonian rat model. Journal of pharmacological sciences, 2012, Volume: 119, Issue:1 Topics: Animals; Behavior, Animal; Corpus Striatum; Dopaminergic Neurons; Fluoxetine; Histones; Levodopa; Male; MAP Kinase Signaling System; Oxidopamine; Parkinson Disease; Phosphorylation; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonergic Neurons; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Substantia Nigra; Tyrosine 3-Monooxygenase	2012

Article

Year

Effect of selective serotonin reuptake inhibitors via 5-HT1A receptors on L-DOPA-induced rotational behavior in a hemiparkinsonian rat model.

Journal of pharmacological sciences, 2012, Volume: 119, Issue:1

Topics: Animals; Behavior, Animal; Corpus Striatum; Dopaminergic Neurons; Fluoxetine; Histones; Levodopa; Male; MAP Kinase Signaling System; Oxidopamine; Parkinson Disease; Phosphorylation; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonergic Neurons; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Substantia Nigra; Tyrosine 3-Monooxygenase

2012